Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Larry Robbins Reduces Stake in Tenet Healthcare Corp by 20.69%, Impacting Portfolio by -2.99%
05:08pm, Friday, 14'th Nov 2025
Insights from Glenview Capital Management's Third Quarter 2025 13F Filing Larry Robbins (Trades, Portfolio) recently submitted the 13F filing for the third qua
Stanley Druckenmiller's Strategic Moves: Exiting Philip Morris International Inc with a -3.65% Impact
03:05pm, Friday, 14'th Nov 2025
Insights into Stanley Druckenmiller (Trades, Portfolio)'s Third Quarter 2025 Portfolio Adjustments Stanley Druckenmiller (Trades, Portfolio) recently submitted
Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business
10:38am, Friday, 14'th Nov 2025
Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business
Quarterly-filed Form 13Fs can clue investors into which stocks and trends are piquing the interest of Wall Street's brightest money managers. Billionaire Stanley Druckenmiller dumped his fund's holdin
Teva Pharmaceutical Industries Limited (TEVA) Presents at UBS Global Healthcare Conference 2025 Transcript
02:51pm, Monday, 10'th Nov 2025
Teva Pharmaceutical Industries Limited ( TEVA ) UBS Global Healthcare Conference 2025 November 10, 2025 8:45 AM EST Company Participants Richard Francis - President, CEO & Director Conference Call Par
Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
10:41am, Monday, 10'th Nov 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
PARSIPPANY, N.J., and TEL AVIV, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the prese
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?
10:41am, Friday, 07'th Nov 2025
Here is how Teva Pharmaceutical Industries Ltd. (TEVA) and Brainsway Ltd.
TEVA Q3 Earnings & Revenues Beat, Austedo Sales View Raised, Stock Up
12:20pm, Thursday, 06'th Nov 2025
Teva stock jumps after third-quarter earnings and revenues top estimates, driven by robust Austedo sales as well as U.S. generics growth.
Why Teva Pharmaceutical Stock Rocked the Market Today
05:53pm, Wednesday, 05'th Nov 2025
The big drugmaker unveiled its latest set of quarterly figures. Thanks to healthy rises in sales of key drugs, its revenue and profitability rose admirably.
Teva Pharmaceuticals CEO on earnings beat: Our shift to biopharma is working
01:02pm, Wednesday, 05'th Nov 2025
Richard Francis, Teva Pharmaceuticals CEO, joins CNBC's 'Money Movers' to discuss the company's most recent quarter, what's driving growth, and much more.
Teva Pharmaceutical Industries Limited (TEVA) Q3 2025 Earnings Call Transcript
01:01pm, Wednesday, 05'th Nov 2025
Teva Pharmaceutical Industries Limited ( TEVA ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Christopher Stevo - Senior Vice President of Investor Relations & Competitive In
Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook
11:30am, Wednesday, 05'th Nov 2025
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its third-quarter 2025 financial results on Wednesday, with total revenue of $4.48 billion, beating analysts' expectations of $4.35 billion, ac
Here's What Key Metrics Tell Us About Teva Pharmaceutical Industries (TEVA) Q3 Earnings
10:31am, Wednesday, 05'th Nov 2025
Although the revenue and EPS for Teva Pharmaceutical Industries (TEVA) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metric
Teva Pharmaceuticals stock surges 12% as branded drug sales outperform
09:14am, Wednesday, 05'th Nov 2025
Teva Pharmaceutical Industries Ltd. stock rose 12% after the company reported stronger-than-expected third-quarter results, buoyed by robust growth in its branded drug portfolio.
